companydata.dkcompanydata.dk

HEMO Invest ApS: Financial statements 2024

CVR: 38403125

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -34,923 and a net result of DKK 2,192,878 compared with DKK 1,477,442 the year before. Equity in the 2024 report amounted to DKK 29,854,634. The solvency ratio was 99.7%. The company had 1 employee in the financial year.

Gross Profit
DKK -34,923
Profit/Loss
DKK 2,192,878
Equity
DKK 29,854,634
Total Assets
DKK 29,940,802
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--35K2.2M29.9M1
2023--62K1.5M28.3M1
2022--29K-3.1M27.6M-
2021--55K17.2M30.8M-
2020--43K8.9M13.7M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

HEMO Invest ApS: The 2023 annual report is outMay 10, 2024

HEMO Invest ApS has published its annual report for 2023. Gross profit came to DKK -61,839, and the net result was DKK 1,477,442.

About HEMO Invest ApS

HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.

Source: annual report 2025, Danish Business Authority